By George Zhanel As we head into another season of influenza and the associated bacterial superinfections that will result, monitoring bacterial pathogens for resistance to our current antimicrobials will take on even greater importance. Antimicrobial resistance surveillance is a priority as, worldwide, we continue to witness the global public health threat of increasing antimicrobial resistance. We can also see that Canada is not immune to this rise of antimicrobial-resistant pathogens. Recently, the Canadian Antimicrobial Resistance Alliance (CARA, www.can-r.com) in partnership with Health Canada, published the results of the CANWARD study, a 10-year (2007-2016) review of trends in antimicrobial-resistant organisms identified among patients seeking care in Canadian hospitals. The eight separate medical paper supplement, published in the Journal of Antimicrobial Chemotherapy (September 2019
from http://besthealthnews.com/2019/10/drug-resistant-infections-on-the-rise-in-canadian-hospitals/?utm_source=rss&utm_medium=rss&utm_campaign=drug-resistant-infections-on-the-rise-in-canadian-hospitals
from
https://healthnews010.tumblr.com/post/188421457383
No comments:
Post a Comment